CM082 and JS001 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC).

NCT03848611 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: CM082 plus JS001

Sponsor

AnewPharma